CapsoVision, Inc. Common Stock Total Assets
CapsoVision, Inc. Common Stock total assets. Based on the latest financial reports, CapsoVision, Inc. Common Stock (CV) holds total assets worth $18.57 Million USD as of June 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see how much is CapsoVision, Inc. Common Stock worth for the company's overall valuation and market capitalisation.
Total Assets of CapsoVision, Inc. Common Stock (2023–2025)
Total assets of CapsoVision, Inc. Common Stock from 2023 to 2025. This chart illustrates how CapsoVision, Inc. Common Stock's total assets have evolved over time, based on quarterly financial data. See CV share price today for real-time trading data and today's change.
CapsoVision, Inc. Common Stock - Asset Composition Analysis
CapsoVision, Inc. Common Stock Total Assets Breakdown (December 2025)
CapsoVision, Inc. Common Stock total assets breakdown as of December 2025. CapsoVision, Inc. Common Stock's total assets of $18.57 Million consist of 91.8% current assets and 8.2% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 55.7% |
| Accounts Receivable | $2.50 Million | 13.8% |
| Inventory | $2.99 Million | 16.4% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2023–2025)
This chart illustrates how CapsoVision, Inc. Common Stock's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore CapsoVision, Inc. Common Stock short-term liquidity ratio to assess how much short-term liquidity the company maintains relative to its equity base.
Key Asset Composition Facts
- Current vs. Non-Current Assets: CapsoVision, Inc. Common Stock's current assets represent 91.8% of total assets in 2025, an increase from 89.2% in 2023.
- Cash Position: Cash and equivalents constituted 55.7% of total assets in 2025, down from 67.6% in 2023.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2023.
- Asset Diversification: The largest asset category is inventory at 16.4% of total assets.
CapsoVision, Inc. Common Stock Competitors by Total Assets
Key competitors of CapsoVision, Inc. Common Stock based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Shenzhen New Industries Biomedical
SHE:300832
|
China | CN¥9.58 Billion |
|
Double Medical Technology Inc
SHE:002901
|
China | CN¥5.03 Billion |
|
BMC Medical Co. Ltd. A
SHE:301367
|
China | CN¥3.59 Billion |
|
SS Innovations International Inc. Common Stock
NASDAQ:SSII
|
USA | $96.98 Million |
|
Emvision Medical Devices Ltd
AU:EMV
|
Australia | AU$24.94 Million |
|
Sequana Medical NV
BR:SEQUA
|
Belgium | €14.57 Million |
|
Hironic Co. Ltd
KQ:149980
|
Korea | ₩80.01 Billion |
|
DRGEM Corporation
KQ:263690
|
Korea | ₩131.65 Billion |
CapsoVision, Inc. Common Stock - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 3.35 | 1.85 | 8.24 |
| Quick Ratio | 2.44 | 1.13 | 6.78 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $12.12 Million | $3.58 Million | $13.05 Million |
CapsoVision, Inc. Common Stock - Advanced Valuation Insights
This section examines the relationship between CapsoVision, Inc. Common Stock's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 24.45 |
| Latest Market Cap to Assets Ratio | 19.39 |
| Asset Growth Rate (YoY) | 8.1% |
| Total Assets | $18.16 Million |
| Market Capitalization | $352.25 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values CapsoVision, Inc. Common Stock's assets at a significant premium (19.39x), suggesting investors see substantial growth potential or unique competitive advantages.
Positive Asset Growth: CapsoVision, Inc. Common Stock's assets grew by 8.1% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for CapsoVision, Inc. Common Stock (2023–2025)
The table below shows the annual total assets of CapsoVision, Inc. Common Stock from 2023 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $18.16 Million | +8.10% |
| 2024-12-31 | $16.80 Million | -21.94% |
| 2023-12-31 | $21.53 Million | -- |
About CapsoVision, Inc. Common Stock
CapsoVision, Inc., a medical technology company, manufactures and markets endoscopic video imaging devices focused on internal imaging of the gastrointestinal system. The company offers CapsoCam Plus, a capsule endoscopy system for visualization of the small bowel mucosa in adults and children aged 2 years and above; and CapsoCam Colon for visualization of the colon and detection and measurement … Read more